Fusion-io FIO shares tumbled 23 percent Thursday morning after a Q4 earnings miss and a reduced Q1 forecast below Street consensus.
FIO saw multiple ratings updates and price target cuts after the miss; here's a rundown:
Market News and Data brought to you by Benzinga APIs- Benchmark - Downgraded from Buy to Hold, lowered PT from $25 to $13. Believes FIO will need to “significantly lower” pricing to attract new, large orders as its Apple and Facebook business matures. Said FIO's guidance “makes us a bit nervous” by relying on a ramping up of very large hyperscale customers starting in 2Q 2014.
- Mizuho - Downgraded from Buy to Neutral, lowered PT from $22 to $13. Intensifying competition lowers operating margin to 2-5%, may make it difficult to improve profitability in future. Unlikely to see upside to stock unless an acquisition surfaces.
- Stifel Nicolaus - Downgraded from Buy to Hold, removes $24 PT. Sees FY2014 guidance as “questionable.” Cited increased competition, lower Flash purchase obligations, and an overall lack of credibility for the downgrade.
- Morgan Stanley - Reiterated Overweight rating, $29 PT. Remains Overweight on potential strategic interest. Aggressive pricing and expanded product lines could accelerate growth back toward the 40% range by the second half of FY2014. Recommends buying on weakness.
- Barclays - Reiterated Equalweight rating, lowered price target from $15 to $13. Says “aggressive” 20 percent revenue growth target is unlikely amidst increasing competition.
- Piper Jaffray - Reiterated Neutral rating, lowered PT from $15 to $12. Still warrants premium multiple over competitors based on strong customer base, history of success, and flurry of M&A activity in the sector.
- Craig Hallum - Maintained Hold rating, lowered PT from $15 to $12
- Credit Suisse - Maintained Outperform rating, lowered PT from $23 to $17
- Goldman Sachs - Maintained Neutral rating, lowered PT from $14 to $13
- Janney - Maintained Neutral rating, lowered PT from $15 to $12
- JPMorgan - Maintained Neutral rating, lowered PT from $21 to $15
- Lazard - Maintained Buy rating, lowered PT from $23 to $17
- Needham - Maintained Buy rating, lowered PT from $20 to $18
- Pacific Crest - Maintained Outperform rating, lowered PT from $19 to $17
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in